VTR Biotech Unveils Advanced Feed Solutions at Major Event
Innovative Feed Solutions at VIV Asia 2025
BANGKOK, THAILAND — VTR Biotech showcased its unique feed solutions at a recent major event known as VIV Asia 2025, one of the foremost global gatherings in the animal feed and livestock sectors. This prominent occasion took place at Impact Bangkok, serving as a hub for industry professionals from around the world to connect, share ideas, and explore cutting-edge technologies and practices.
Fostering a Sustainable Future
VTR Biotech emphasized the pressing need for sustainable and cost-efficient feed solutions as global demand rises. The company has been developing advanced feed enzymes like phytase, protease, xylanase, and Macleaya cordata extract, each crafted to improve feed efficiency, lower production costs, and bolster the economic outcomes for producers in the animal feed space.
Technical Insights from Industry Experts
During the event, VTR Biotech hosted a noteworthy technical session titled “Optimizing Economic Efficiency of Production with Exogenous Feed Enzymes”. This insightful discussion was led by Dr. Juan Antonio Javierre, a recognized authority in the fields of feed optimization and biotechnology. Attendees learned how integrating exogenous feed enzymes can significantly transform animal production practices, paving the way for enhanced sustainability and profitability.
Responding to Industry Challenges
Amid increasing pressures related to feed cost inflation and the necessity for sustainable practices, VTR Biotech is committed to offering innovative solutions. The company’s recent advancements include a multifunctional enzyme that surpasses traditional single-enzymes by optimizing feed utilization and digestibility. This cutting-edge tool supports optimal poultry health while also reducing feed costs, proving to be essential in overcoming the challenges facing the feed industry today.
Diverse Portfolio of Advanced Solutions
VTR Biotech has developed an extensive range of feed solutions tailored to enhance efficiency in animal production. Each enzyme is specifically formulated to cater to the evolving needs within the animal feed sector, ensuring producers can meet market demands effectively.
Breakthrough Enzyme Innovations
Below are some of the highlighted innovations presented at VIV Asia 2025 that showcase VTR Biotech’s leadership in feed enzyme development:
- Microtech Phytase: This innovation explores microbial enzyme technology to optimize feed performance, significantly enhancing animal health and nutrient absorption.
- Acid Protease: By improving protein digestion in acidic environments, this enzyme optimizes feed conversion, ultimately lowering feed expenses while amplifying animal growth and health.
- Xylanase: Known for enhancing fiber digestion, VTR Biotech’s Yiduozyme xylanase allows for more effective feed utilization, thus promoting better overall animal health.
- Glucose Oxidase: A notable improvement in poultry gut health has been observed with this innovation, aiding in overall performance and decreasing feed costs.
- Lipase: This enzyme plays a vital role in fat digestion, helping to maximize nutrient absorption and enhance weight gains across various livestock.
- ?-mannanase: By breaking down non-starch polysaccharides, this enzyme boosts nutrient availability and minimizes feed waste, significantly contributing to animal wellbeing.
- Macleaya Cordata Extract: This natural extract supports animal health, improves feed efficiency, and minimizes oxidative stress.
About VTR Biotech
VTR Biotech stands at the forefront of global biotechnology, specializing in advanced feed enzymes and bioproducts. The company's commitment to sustainability and innovation helps enhance animal health and promote responsible agricultural methods worldwide.
Contacting VTR Biotech
For more information about VTR Biotech's innovative solutions, feel free to reach out via their website or email.
Contact: VTR Biotech
Email: vtr@vtrbio.com
Website: www.vtrbiotech.com
Frequently Asked Questions
What innovations did VTR Biotech present at VIV Asia 2025?
VTR Biotech unveiled a range of advanced feed enzymes intended to improve efficiency and sustainability in animal production.
Who led the technical session at the event?
Dr. Juan Antonio Javierre, an expert in feed optimization, conducted the session titled “Optimizing Economic Efficiency of Production with Exogenous Feed Enzymes.”
What is the significance of the multifunctional enzyme introduced by VTR Biotech?
The multifunctional enzyme improves feed utilization, offers cost-saving benefits, and supports optimal poultry health.
How does VTR Biotech contribute to sustainability in animal feed production?
The company focuses on developing solutions that enhance feed efficiency and reduce overall production costs, crucial for sustainable practices.
Where can I learn more about VTR Biotech's products?
For detailed information regarding their products and innovations, visit their official website at www.vtrbiotech.com.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
